| [1] |
Gowing LR，Ali RL，Allsop S，et al.Global statistics on addictive behaviours：2014 status report[J].Addiction，2015，110（6）：904-919.
|
| [2] |
Di Castelnuovo A，Costanzo S，Bagnardi V，et al.Alcohol dosing and total mortality in men and women：an updated meta-analysis of 34 prospective studies[J].Arch Intern Med，2006，166（22）：2437-2445.
|
| [3] |
Roerecke M，Rehm J.The cardioprotective association of average alcohol consumption and ischaemic heart disease：a systematic review and meta-analysis[J].Addiction，2012，107（7）：1246-1260.
|
| [4] |
Walker RK，Cousins VM，Umoh NA，et al.The good，the bad，and the ugly with alcohol use and abuse on the heart[J].Alcohol Clin Exp Res，2013，37（8）：1253-1260.
|
| [5] |
Brien SE，Ronksley PE，Turner BJ，et al.Effect of alcohol consumption on biological markers associated with risk of coronary heart disease：systematic review and meta-analysis of interventional studies[J].BMJ，2011，342：d636.
|
| [6] |
Navab M，Reddy ST，Van Lenten BJ，et al.HDL and cardiovascular disease：atherogenic and atheroprotective mechanisms[J].Nat Rev Cardiol，2011，8（4）：222-232.
|
| [7] |
Zhu W，Cheng KK，Vanhoutte PM，et al.Vascular effects of adiponectin：molecular mechanisms and potential therapeutic intervention[J].Clin Sci，2008，114（5）：361-374.
|
| [8] |
Tian C，Jin X，Ye X，et al.Long term intake of 0.1% ethanol decreases serum adiponectin by suppressing PPARγ expression via p38 MAPK pathway[J].Food Chem Toxicol，2014，65：329-334.
|
| [9] |
Lee S，Kwak HB.Role of adiponectin in metabolic and cardiovascular disease[J].J Exerc Rehabil，2014，10（2）：54-59.
|
| [10] |
Zhang RH，Gao JY，Guo HT，et al.Inhibition of CYP2E1 attenuates chronic alcohol intake -induced myocardial contractile dysfunction and apoptosis[J].Biochim Biophys Acta，2013，1832（1）：128-141.
|
| [11] |
Zhang Y，Ren J.ALDH2 in alcoholic heart diseases：molecular mechanism and clinical implications [J].Pharmacol Ther，2011，132（1）：86-95.
|
| [12] |
Alatalo PI，Koivisto HM，Hietala JP，et al.Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid—an index of oxidant stress status?[J].Free Radic Biol Med，2009，46（8）：1233-1238.
|
| [13] |
ZS Kaplan，SP Jackson.The role of platelets in atherothrombosis[J].Hematology，2011，2011（4）：51-61.
|
| [16] |
George A，Figueredo VM.Alcoholic cardiomyopathy：a review[J].J Card Fail，2011，17（10）：844-849.
|
| [22] |
Son Y，Kim S，Chung HT，et al.Reactive oxygen species in the activation of MAP kinases[J].Methods Enzymol，2013，528：27-48.
|
| [28] |
Orogo AM，Gustafsson AB.Cell death in the myocardium：my heart won't go on[J].IUBMB Life，2013，65（8）：651-656.
|
| [14] |
Nanji AA，Liong EC，Xiao J，et al.Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations[J].Alcohol Clin Exp Res，2013，37（1）：31-39.
|
| [15] |
Levy JH，Welsby I，Goodnough LT.Fibrinogen as a therapeutic target for bleeding：a review of critical levels and replacement therapy[J].Transfusion，2014，54（5）：1389-1405.
|
| [17] |
Tan Y，Li X，Prabhu SD，et al.AngiotensinⅡplays a critical role in alcohol-induced cardiac nitrative damage，cell death，remodeling，and cardiomyopathy in a protein kinase C/nicotinamide adenine dinucleotide phosphate oxidase-dependent manner[J].J Am Coll Cardiol，2012，59（16）：1477-1486.
|
| [18] |
Shearer F，Lang CC，Struthers AD.Renin-angiotensin-aldosterone system inhibitors in heart failure[J].Clin Pharmacol Ther，2013，94（4）：459-467.
|
| [19] |
Rosenbaugh EG，Savalia KK，Manickam DS，et al.Antioxidant-based therapies for angiotensinⅡ-associated cardiovascular diseases[J].Am J Physiol Regul Integr Comp Physiol，2013，304（11）：R917-R928.
|
| [20] |
Hajnóczky G，Buzas CJ，Pacher P，et al.Alcohol and mitochondria in cardiac apoptosis：mechanisms and visualization[J].Alcohol Clin Exp Res，2005，29（5）：693-701.
|
| [21] |
Li R，Zheng W，Pi R，et al.Activation of peroxisome proliferator-activated receptor-α prevents glycogen synthase 3β phosphorylation and inhibits cardiac hypertrophy[J].FEBS Lett，2007，581（17）：3311-3316.
|
| [23] |
Aoyagi T，Matsui T.Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure[J].Curr Pharm Des，2011，17（18）：1818-1824.
|
| [24] |
Doser TA，Turdi S，Thomas DP，et al.Transgenic overexpression of aldehyde dehydrogenase -2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction[J].Circulation，2009，119（14）：1941-1949.
|
| [25] |
Shahbaz AU，Sun Y，Bhattacharya SK，et al.Fibrosis in hypertensive heart disease：molecular pathways and cardioprotective strategies[J].J Hypertens，2010，28（Suppl 1）：S25-S32.
|
| [26] |
Law BA，Carver WE.Activation of cardiac fibroblasts by ethanol is blocked by TGF-β inhibition[J].Alcohol Clin Exp Res，2013，37（8）：1286-1294.
|
| [27] |
Ojeda ML，Barrero MJ，Nogales F，et al.Oxidative effects of chronic ethanol consumption on the functions of heart and kidney：folic acid supplementation [J].Alcohol Alco hol，2012，47（4）：404-412.
|
| [29] |
Jing L，Jin C，Li S，et al.Chronic alcohol intake-induced oxidative stress and apoptosis：role of CYP2E1 and calpain-1 in alcoholic cardiomyopathy[J].Mol Cell Biochem，2012，359（1-2）：283-292.
|
| [30] |
Tsutsui H，Kinugawa S，Matsushima S.Oxidative stress and heart failure[J].Am J Physiol Heart Circ Physiol，2011，301（6）：H2181-H2190.
|
| [31] |
Burgoyne J R，Mongue-Din H，Eaton P，et al.Redox signaling in cardiac physiology and pathology[J].Circ Res，2012，111（8）：1091-1106.
|
